Treatment
wart, pain
WARTS, WART, RECURRENCE
Since the first session of vitamin D3 injections without Anastasia caused pain for all patients, 0.2 mL of lignocaine (20 mg/mL) was injected into the base of each wart slowly using a gage 27 needle. This was followed by the slow injection of 0.2 mL of vitamin D3 solution (600 000 IU; 15 mg/mL) (Figure Vitamin D3 ampoules (600 000 IU).Lesions were measured before and after therapy to record how well the lesions responded to the treatment. To detect any recurrence, the patients were monitored for a full 6 months after their final injection. Before and after measurements of all cutaneous warts were taken during treatment in order to evaluate the efficacy of the procedure. Photographic measurements were taken at the beginning, after 8 weeks, and after 6 months for the clinical evaluation. Patients were considered to have a partial response if they experienced a 50% or higher reduction in the size and quantity of warts and to have not responded if they experienced a decrease of less than 50%.